January 18, 2018 1:29 AM ET


Company Overview of G Drugs and Pharmaceuticals Limited

Company Overview

As of April 20, 2012, G Drugs and Pharmaceuticals Limited was acquired by IOL Chemicals and Pharmaceuticals Ltd. G Drugs and Pharmaceuticals Limited manufactures IBAP and IPCA, Ibuprofen intermediates. The company was incorporated in 1997 and is based in Ludhiana, India.

85-Industrial Area A

Ludhiana,  141003


Founded in 1997


91 16 1264 0531


91 16 1260 8784

Key Executives for G Drugs and Pharmaceuticals Limited

G Drugs and Pharmaceuticals Limited does not have any Key Executives recorded.

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact G Drugs and Pharmaceuticals Limited, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.